Chromium Picolinate.
Blood sugar mineral. Insulin sensitivity support. Supplies chromium in a form that crosses the gut lining readily, supporting normal macronutrient metabolism and insulin signalling. It works on markers, not on mood.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- Blood sugarInsulinCravings
What Chromium Picolinate is, and what it does.
- Does it work
- Suits people supporting healthy glucose metabolism, especially on a carbohydrate-heavy or narrow diet. A varied mixed diet already supplies chromium.
- How much to take
- Start with 200mcg a day, with 500mcg the top of the everyday band. 800mcg is a research condition rather than a daily target.
- Time to feel it
- About two months of daily use, with further change by four months.
- The first dose
- Quiet. The complex is absorbed and on transferrin within hours, but what it does is metabolic and accumulates over weeks.
- With regular use
- Across eight to twelve weeks of daily use, any change registers on fasting glucose and insulin readings. Some people also describe fewer mid-afternoon pulls toward sugar.
- How well tolerated
- Well tolerated at the microgram servings used in supplements. Talk to your doctor first if you take glucose medicines, and space it away from a large iron serving.
- How it feels
- Mostly like nothing in the moment. Some people describe fewer mid-afternoon pulls toward sugar after a few weeks; the rest sits on a blood panel.
- The overlooked benefit
- Picolinic acid is a tryptophan metabolite your own body makes. Three of them wrap the chromium into a neutral, fat-friendly complex that crosses the gut lining readily.
200 to 500mcg a day is where Chromium Picolinate works.
Source: NIH ODS + Cefalu 2010 review
In a randomised trial of 180 adults treated for type 2 diabetes, supplemental chromium as chromium picolinate at 200 or 1,000 micrograms per day was compared with placebo. HbA1c improved after 2 months in the 1,000 microgram group and was lower in both chromium groups after 4 months, and fasting glucose was lower in the 1,000 microgram group at both 2 and 4 months. A later 4-month randomised trial in 71 adults with poorly controlled type 2 diabetes at 600 micrograms per day reported lower fasting and postprandial glucose. No washout period was measured.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Based on 50 human trials with 60% consistency.
- Healthy glucose metabolismMeta-analysis
- Normal insulin receptor signallingIn vitro study
- Body weight and body compositionMeta-analysis
- Appetite and food cravingsRandomised trial
- Normal macronutrient metabolismNarrative review
Questions people ask about Chromium Picolinate.
- When should I take it?
- With food, ideally a meal containing some fat for better absorption. Morning or evening, pick one and stick with it.
- How long until I notice something?
- If you're deficient, you might notice within 1-2 weeks. For general maintenance, give it 4-8 weeks.
- Can I get enough from food?
- Sometimes. If your diet is solid and varied, you might not need to supplement. But deficiency is more common than most people think. A blood test is the only way to know for sure.
- Can I take too much?
- Yes. More isn't better with minerals. Stick to the recommended dose. High doses can compete with other minerals for absorption.
- Can I take it with other supplements?
- Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
- Who benefits most from this?
- People with a specific, evidence-backed need. Chromium Picolinate has strong research. If your situation matches the studied use case, it's one of the more reliable supplements you can take.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Chromium supports insulin's normal signaling at the cell surface while biotin acts as a cofactor for the carboxylase enzymes in glucose and fatty acid metabolism, so each covers a different step in how the body handles carbohydrates. That complementary split is the long-standing reason the two are formulated together.
Vitamin C taken at the same time as chromium appears to increase how much of the mineral the gut absorbs, because ascorbic acid keeps chromium in a more soluble, better absorbed form as it moves through the digestive tract.
Trivalent chromium is carried in blood on transferrin, the same protein iron binds, so a large iron load occupies binding sites chromium uses. High iron intakes and chromium therefore work against each other at the transport step.
Nicotinic acid coordinates trivalent chromium much as picolinate does, and formulas often carry both ligand forms so the mineral has more than one absorbable carrier. How much the ligand choice matters biologically is still open.
Zinc and chromium compete for overlapping cation uptake pathways in the small intestine. Large simultaneous doses lower absorption of both, and spacing them apart removes the competition.
Carbonate raises gastric pH and chromium needs an acid environment to stay soluble for absorption. Calcium ions compete at the same uptake step as well.
Both are studied for effects on how cells handle glucose, by different routes: alpha-lipoic acid acts on mitochondrial redox and glucose uptake, trivalent chromium on insulin signal amplification. Taken together the glucose-lowering directions add rather than cancel. Anyone already using medication or agents that lower blood sugar should have the combination reviewed by a clinician, since additive effects are the point here.
Cinnamon polyphenols and chromium picolinate are both routinely formulated into the same glucose-support blends and both act on post-meal glucose handling. The effects are directionally the same, so the pair is additive rather than complementary. Reported effect sizes for each are modest and measured mostly as blood markers, not long-term outcomes.
Berberine activates AMPK and increases peripheral glucose uptake; chromium supports normal insulin signalling. Stacked, their glucose-lowering directions add. This is a combination to flag rather than to assume, because additive glycaemic effects matter most in people already on glucose-lowering medication.
Gymnemic acids blunt sweet taste perception and reduce intestinal glucose absorption, a different step from chromium's action on insulin signalling. The two are commonly co-formulated for that reason. Evidence for the pair specifically is not established; each has its own separate literature.
Bitter melon cucurbitane triterpenoids act on glucose transport at the cell membrane while chromium acts on the insulin receptor cascade. The effects point the same way. Human data for bitter melon is thinner than for chromium, so the pairing is early rather than settled.
1-deoxynojirimycin inhibits intestinal alpha-glucosidase, flattening the post-meal glucose rise before absorption. Chromium acts after absorption, at the level of insulin signalling. The two act at different points on the same curve, which is why they are often combined.
A 2026 meta-analysis grouped magnesium, chromium, zinc and selenium as minerals studied for effects on insulin resistance indices. Magnesium is a cofactor for the insulin receptor tyrosine kinase, chromium is associated with amplification of the same signal downstream. The measured endpoints in that literature are markers of insulin sensitivity, not clinical outcomes.
Selenium and chromium appear together in mineral supplementation reviews and share intestinal handling routes at high single doses. Co-occurrence indexing flags the pair as antagonistic in some contexts, which fits competition for absorption rather than an interaction after uptake. Separating the doses across the day sidesteps the question.
Copper is one of the most frequently co-studied elements with chromium in the trace-element literature. Trace metals given as a large single bolus compete for shared intestinal transporters and for plasma binding proteins. Ordinary dietary amounts of either are not the concern; concentrated single-dose stacking is.
A 2026 animal study fed chromium picolinate and sodium bicarbonate in combination and tracked growth performance and rumen fermentation. The measurements were made in livestock, not people, so nothing transfers directly. It does show the two have been formulated together and studied as a pair.
Catechins slow carbohydrate digestion and modestly affect glucose disposal, a direction shared with chromium. Green tea polyphenols also chelate metal ions in the gut, so a large simultaneous dose may reduce mineral uptake. That makes this both an additive pairing on the glycaemic side and a spacing question on the mineral side.
Psyllium forms a viscous gel that slows gastric emptying and flattens the post-meal glucose curve. Chromium works after absorption. Viscous fibre also delays or reduces the uptake of minerals taken in the same dose, so separating them by a couple of hours is the practical formulation answer.
Inulin is fermented to short-chain fatty acids that acidify the colonic lumen, and a lower luminal pH keeps some mineral cations soluble. This is described for calcium and magnesium more than for chromium. The read-across to chromium is plausible chemistry rather than measured fact.
Talk to a doctor before taking Chromium Picolinate if any of these apply to you: diabetes meds. These are flags to check first, not effects Chromium Picolinate is known to cause.
Not medical advice. Show the label to your pharmacist.What Chromium Picolinate actually does.
Chromium in supplements is trivalent chromium, chemically and toxicologically distinct from the hexavalent form used in industry. The two are not interchangeable and the trivalent form is the one present in food and in picolinate chelates.
Picolinic acid is a metabolite of the tryptophan-kynurenine pathway and a bidentate chelator. Three picolinate ligands wrap a single chromium(III) ion, giving a neutral, lipophilic complex that crosses the intestinal membrane more readily than an inorganic chromium salt.
Absorbed chromium(III) binds transferrin and shares that carrier with iron, which is why iron status influences chromium transport and why the two minerals interact at the level of plasma binding rather than at the receptor.
Chromium absorption from any form is low in absolute terms, in the low single-digit percentage range, so the practical differences between chromium forms are differences between small numbers.
Where Chromium Picolinate comes from.
It is made in a chemistry plant rather than grown. Chromium from mineral ore is bonded to picolinic acid, a molecule the body itself makes from tryptophan, and the resulting pink powder is tested for how much chromium it holds before it goes into a capsule.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Chromium chloride hexahydrate or chromium nitrate, produced from chromite ore that has been processed and reduced to the trivalent state
2-pyridinecarboxylic acid, made industrially by oxidation of 2-methylpyridine (2-picoline) or via related pyridine chemistry
The chromium(III) salt and picolinic acid are reacted in aqueous solution with pH adjustment, and three picolinate ligands coordinate one chromium ion to give a neutral complex
The complex precipitates as a pink to violet solid and is filtered, washed to remove unreacted salt and free ligand, and dried
Batches are assayed for total chromium content, commonly around 12 percent by mass for the tris-picolinate complex, and screened for hexavalent chromium and heavy metals
Milled and blended with carriers, then compressed or encapsulated at microgram-level doses
Ore source and the specific chromium salt used as starting material are not usually stated on a label.
Getting Chromium Picolinate from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
Chromium Picolinate is a form of Chromium.
Chromium Picolinate is the picolinate form of Chromium. Same mineral, bound to a different partner, so absorption and feel differ from form to form.
See the other 1 form
The essence, in one line each.
- In a meta-analysis of 25 randomized trials in adults managing blood sugar, chromium supplementation lowered HbA1c by about 0.55 percentage points and fasting glucose by about 1.15 mmol/L, with the glucose effect most evident for chromium picolinate.Meta-analysis. Suksomboon et al., 2014 (Journal of Clinical Pharmacy and Therapeutics). PMID 24635480 ↗
- Pooling 1,316 participants with excess body weight, chromium supplementation was associated with about 0.75 kg more weight loss and about 0.68 percentage points lower body fat than placebo, a small effect the authors call of uncertain clinical relevance.Meta-analysis. Tsang et al., 2019 (Clinical Obesity). PMID 31115179 ↗
- Pooling six trials in 392 adults carrying excess body weight, chromium picolinate at 200 to 1000 micrograms lowered body weight by 1.1 kg over 12 to 16 weeks (95% CI -1.7 to -0.4) on low-quality evidence, with no dose gradient established.Meta-analysis. Tian et al., 2013 (Cochrane Database of Systematic Reviews). PMID 24293292 ↗
- Across 14 randomised trials in adults with elevated blood sugar, chromium supplementation did not measurably change body weight (-0.26 kg), BMI, waist circumference or fat mass, with a fat-mass reduction seen only in subgroups aged 55 and over and on the picolinate form.Meta-analysis. Vajdi et al., 2024 (Journal of Trace Elements in Medicine and Biology). PMID 37952433 ↗
- In 40 adults with clustered metabolic risk factors, 400 micrograms of chromium picolinate daily for 12 weeks lowered the blood marker HbA1c by 0.68%, raised HDL cholesterol by 4.8 mg/dL and lowered systolic blood pressure by 4.8 mmHg, with no change in DNA-damage or inflammatory gene markers.Randomised trial. Ebrahimzadehkour et al., 2026 (Biological Trace Element Research). PMID 41840296 ↗
- Oral chromium picolinate was reported to improve glycaemic control markers in the supplemented group.Randomised trial. Paiva et al., 2015 (Journal of Trace Elements in Medicine and Biology). PMID 26302914 ↗
- Supplementation was reported to shift several cardiometabolic blood markers; these are markers, not clinical outcomes.Randomised trial. Talab et al., 2020 (Clinical Nutrition Research). PMID 32395440 ↗
- A pilot study tracked serum fetuin-A along with metabolic and inflammatory blood markers during chromium picolinate supplementation.Open-label trial. Moradi et al., 2021 (Journal of Trace Elements in Medicine and Biology). PMID 33045675 ↗
- A published protocol describing a planned randomised trial of chromium picolinate; it reports design, not results.Randomised trial. Mozaffari-Khosravi et al., 2021 (Saudi Journal of Kidney Diseases and Transplantation). PMID 35946280 ↗
- A pooled analysis of mineral supplements including chromium picolinate reported effects on insulin resistance indices, which are calculated markers.Meta-analysis. Ye et al., 2026 (BMC Endocrine Disorders). PMID 41580698 ↗
- An extensive review of chromium supplementation found the human literature mixed, with heterogeneity in dose, form and baseline status.Systematic review. Georgaki et al., 2024 (Environmental Geochemistry and Health). PMID 39541030 ↗
- Pooled poultry trials reported improved growth performance with dietary chromium picolinate; this is livestock data and does not transfer to people.Meta-analysis. Feng et al., 2021 (PLoS One). PMID 33822801 ↗
- Dietary chromium picolinate was reported to improve glucose utilisation and insulin response in transition calves.Animal study. Khare et al., 2023 (Biological Trace Element Research). PMID 36066751 ↗
- Chromium picolinate in feed was reported to change growth, body composition and biochemical parameters in fish.Animal study. Li et al., 2018 (Fish Physiology and Biochemistry). PMID 29961187 ↗
- Supplementation was reported to change cardiac performance measures in rats held under low-oxygen conditions.Animal study. Abdel-Hady et al., 2024 (Acta Cardiologica). PMID 36044000 ↗
- Chromium picolinate combined with strength training altered cardiomyocyte relaxation measures in an animal model.Animal study. Miranda et al., 2026 (Biomedicines). PMID 42351674 ↗
- Chromium picolinate given with sodium bicarbonate changed growth performance and rumen fermentation measures.Animal study. Gunuc et al., 2026 (Tropical Animal Health and Production). PMID 42329543 ↗
- Quantified production responses to chromium supplementation in lactating dairy cattle; an agricultural production endpoint, not a human health one.Meta-analysis. Roman-Garcia et al., 2026 (Journal of Dairy Science). PMID 41651358 ↗
These are the studies our verdict leans on, chosen from the 1,483 we read for Chromium Picolinate. The full linked list is below.
The studies, linked.
7 sources behind our Chromium Picolinate verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialEfficacy of Chromium Picolinate in Reducing Acanthosis Nigricans Severity in Adolescents With Insulin ResistanceClinicalTrials.gov ↗NA · 90 participants · Completed
- Clinical trialA Double-Blind Randomized Controlled Clinical Trial of Chromium Picolinate on Clinical and Biochemical Features of the Metabolic SyndromeClinicalTrials.gov ↗NA · 60 participants · Completed
- Clinical trial"A Randomized, Double Blinded, Placebo Controlled, Parallel Arm, Study to Evaluate the Improvement in Glycemic Control After Daily Administration of Chromium Picolinate and Biotin in Patients With Type 2 Diabetes Mellitus"ClinicalTrials.gov ↗NA · 40 participants · Completed
- Clinical trialA Novel Therapy for Glucose Intolerance in HIV DiseaseClinicalTrials.gov ↗PHASE1 · 39 participants · Completed
- Clinical trialEffect of Chromium Picolinate on Metabolic and Physiologic Parameters in Type 2 DiabetesClinicalTrials.gov ↗PHASE4 · 30 participants · Completed
- Clinical trialImpact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Pregnant Women with Gestational Diabetes MellitusClinicalTrials.gov ↗PHASE1 · 200 participants · Not yet recruiting
- Clinical trialDoes Oral Chromium Withstand Steroid Hyperglycemia in Post-interventional Ultrasound Guided Sacroiliac Joint Injection in Diabetic PatientsClinicalTrials.gov ↗PHASE4 · 60 participants · Active not recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 3,037 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Chromium Picolinate is, not how risky it is. A report is not proof Chromium Picolinate caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
